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TObjective: Beyond the first 2 months of life, pulmonary artery banding is warranted
before two-stage arterial switch operation. The aim of this study was to explore
whether myogenic cell transplantation could contribute to right ventricular function
during pulmonary artery constriction in an ovine model.
Methods: Sixteen rams were assigned to one of the following groups: group 1, simple
pulmonary artery banding (n  5); group 2, pulmonary artery banding and cell
implantation in the right ventricle (n  7); and group 3, pulmonary artery banding and
placebo injection in the right ventricle (n 4). Hemodynamic assessment with pressure-
volume loops was performed on days 0 and 60. The pulmonary artery banding and the
injections were achieved through a left fourth intercostal thoracotomy. Autologous
myogenic cell implantation was carried out with a noncultured cell preparation, as
previously described by our group. Implanted sites were processed with monoclonal
antibodies to a fast skeletal-specific isoform of myosin heavy chain (MY32).
Results: Skeletal myosin heavy chain expression was detected at 2 months after
noncultured cell implantation in all grafted animals. Right ventricular training
resulted in statistically significant increased signs of contractility in all three groups.
There was no observed difference, however, between the cell therapy group and the
other two groups with respect to signs of cardiac function.
Conclusion: Successful engraftment of noncultured cells into right ventricular
myocardium did not translate into a functional benefit that we could demonstrate in
our ovine model. Cellular therapy thus is probably not useful to strengthen a left
ventricle being retrained through pulmonary artery banding before arterial switch
operation. However, cell transplantation may affect the outcome of right ventricular
failure long term after atrial switch operation. Although preliminary, this investi-
gation paves the way for further research into cellular cardiomyoplasty, right
ventricular failure, and congenital heart disease.
Transposition of the great arteries is a heart defect that is found in approxi-mately 5% of all neonates with congenital heart malformations.1 Currently,the operation of choice for transposition of the great arteries is the one-stage
arterial switch operation (ASO). After birth, progressive regression of the left
ventricular mass in simple transposition of the great arteries2,3 restricts the safe
period for primary ASO to the first 14 or 25 months of life. If the left ventricle is not
able to maintain a systemic pressure, left ventricular retraining is mandatory before
switching the morphologically left ventricle under the aorta. Currently, this is achieved
by creating a ventricular overload through pulmonary artery banding (PAB) and pos-
sibly associated aortopulmonary shunt. First performed by Yacoub and colleagues6 in
1977, left ventricular retraining has shown its limits7; the increase in mass of the left
ventricle is accomplished beyond the neonatal period by simple hypertrophy and not by
hyperplasia of cardiomyocytes.8
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DThe concept of myogenic cell transplantation into the
myocardium, cellular cardiomyoplasty (CCM), is based on
the contribution of exogenous cells to replace lost or altered
cardiomyocytes to restore functional performance of the
heart.9 There is a large body of evidence showing that CCM
can improve cardiac function in ischemic heart disease (see
recent review10). Thus far, teams have mostly addressed
acquired diseases of the adult.11 The aim of this study was
therefore to explore whether myogenic cell transplantation
could contribute to the hypertrophy obtained by increased
right ventricular afterload through PAB in an ovine model.
We hypothesized that CCM and PAB would yield better
hemodynamic results than PAB alone.
Methods
Animal Model
The study was approved by the institutional ethics committee for
animal research, and all animals received humane care in compli-
ance with the “Guide for the Care and Use of Laboratory Animals”
(http://www.nap.edu/catalog/5140.html).
Experimental Design
The experimental design was as follows. Sixteen 40  4-kg
4-month-old Ile de France rams were randomly assigned to one of
the following groups: group 1, simple PAB (n  5); group 2, PAB
and cell implantation in the right ventricle (n  7); and group 3,
PAB and placebo injection in the right ventricle (n  4). Hemo-
dynamic assessment was performed on day 0 (just before PB) and
at day 60 (just before the animals were put to death).
Anesthesia and Analgesia
Animals were anesthetized with midazolam and etomidate, allow-
ing endotracheal intubation and maintenance with isoflurane in
oxygen, delivered with a ventilator (Hallowell Engineering and
Manufacturing Corporation, Pittsfield, Mass). During pressure-
volume loop analysis, fluid therapy, depth of anesthesia, and
ventilation were adjusted so that pressure and end-tidal carbon
dioxide were within normal ranges. The animals were left to
recover with the required analgesic regimen after surgery and the
following day as needed.
Right Ventricular Catheterization and Pressure-
Volume Loop Analysis
Contractile performance of the right ventricle was assessed before
and 2 months after PAB with preload recruitable stroke work
(PRSW), the relationship between stroke work and right ventric-
ular end-diastolic volume. Right ventricular volume measurement
was performed with the conductance catheter method applied to
the right ventricle, as previously described by Hon and cowork-
ers.12 Parallel conductance was measured with the hypertonic
saline method.13 Reference cardiac output was measured in trip-
licate in all animals by using the thermodilution technique.14 The
mean of three consecutive measurements was recorded and saved
for off-line factor  calibration.
After pressure calibration, a 6F combined conductance-
pressure catheter (Millar Instruments, Inc, Houston, Tex) was
advanced through the femoral vein introducer into the right ven-
1120 The Journal of Thoracic and Cardiovascular Surgery ● Matricle. The conductance catheter was connected to a Leycom Sig-
ma-5 signal conditioner processor (CardioDynamics, San Diego,
Calif) to obtain an instantaneous right ventricular volume signal.
Real-time signal processing was obtained on a dedicated software
(IOX; Emka Technologies SA, Paris, France). At least 10 pressure-
volume loops were obtained during apnea at end-expiratory pres-
sure and analyzed off-line for  calibration and to calculate de-
veloped pressure (systolic pressure minus diastolic pressure),
maximum and minimum rates of change of pressure inside the
right ventricle (dP/dtmax and dP/dtmin, respectively). A 23-mm
balloon catheter was advanced into the caudal vena cava for inflow
occlusion. A series of three caval occlusions was obtained. Pres-
sure-volume loop assessment at day 0 was followed by PAB in all
three groups; additionally, either noncultured cell implantation
(group 2) or placebo injection (group 3) was performed in the right
ventricular wall.
Pulmonary Artery Banding
A left fourth intercostal thoracotomy was performed. The pulmo-
nary trunk was dissected at its mid portion. The right ventricular
pressure was monitored by direct catheterization. Baseline right
ventricular pressure, pulmonary pressure, and maximal right ven-
tricular pressure were recorded. The PAB was achieved with a
4-mm wide Dacron polyester fabric band. After dissection, the
Dacron tape was passed around the pulmonary trunk. The degree
of PAB was adjusted as previously described by Mee.15 The band
was then sutured in its tightened position with 5-0 Prolene suture
(Ethicon, Inc, Somerville, NJ). Animals were left to recover and
were reoperated on 2 months later for final assessment.
Skeletal Muscle Biopsy
Animals of group 2 were anesthetized 3 hours before PAB to
perform the muscle biopsy. Approximately 10 g muscle tissue was
explanted from the left femoral biceps under sterile conditions.
The biopsy tissue was kept at room temperature until mechanical
and enzymatic digestions were started. The operative wound was
closed in a routine fashion.
Muscle Cell Extraction
In animals of group 2, the noncultured cell preparation was per-
formed as previously described by our group.16 This technique is
based on the extraction of satellite cells from a skeletal muscle,
mechanical and enzymatic digestion, and reimplantation of the cell
preparation approximately 3 hours after muscle biopsy. Briefly, the
muscle was minced with scissors to a slurry. To release satellite
cells, the muscle fragments were then incubated at 37°C under
agitation in 10 mL of Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 0.2 % (weight/volume) crude colla-
genase. After 20 minutes, the fragments were centrifuged at 300
rpm for 2 minutes. The supernatant containing isolated cells was
stored in DMEM; the pellet was then subjected to four more
rounds of digestion. The extracted cells were then filtered through
a nylon cell strainer (VWR-Polylabo, Strasbourg, France). The cell
preparation was then resuspended in 2 mL (first 2 animals of group
2) or 1.2 mL (remaining 5 animals of group 2) of serum-free
DMEM and kept at 4°C until implantation. A previous study
allowed to determine that 1.7  0.3  107 mononucleated cells
were injected per animal.16
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To confirm the presence of muscle precursor cells in the cell
preparation, a 100-L aliquot of the cell suspension was plated in
a flask containing fetal calf serum completed DMEM. The cells
were then grown as a control in humid air with 5% carbon dioxide.
One week after plating, cells were processed for immunodetection
of MyoD as previously described by Montarras and associates.17
Cell Implantation into Right Ventricular Myocardium
After PAB, landmarks were made with 5-0 polypropylene suture
material on the right ventricular free wall. Twenty (first 2 animals
of group 2) and then 10 epicardial 100-L injections of the cell
Figure 1. To confirm presence of muscle precursor cells in cell
preparation, 100-L aliquot of cell suspension was plated in
culture flask containing fetal calf serum completed DMEM. Cells
were then grown as control. At 3 to 7 days after plating, cells
were processed for immunodetection of skeletal muscle–specific
regulatory factor MyoD. At least 50% of cultured cells (nuclei
stained with 4’,6-diamidino-2-phenylindole [DAPI] in A) were
skeletal muscle precursor cells (B, green).preparation (5 remaining animals of group 2) or medium (4 control
The Journal of Thoracicanimals of group 3) were carried out with a 27-gauge infusion set
(Vygon Corporation, East Rutherford, NJ). Five injections were
performed in the infundibulum about 10 mm apart; five additional
injections were performed in the rest of the right ventricle. A
0.1-mg/kg intramuscular injection of dexamethasone was per-
formed before closing to reduce the inflammation associated with
the numerous intramyocardial punctures (pilot study, data not
Figure 2. A, Skeletal myosin heavy chain (MY32) expression
(brown) was detected at 2 months after noncultured cell implan-
tation in 5 of 5 animals in group 2, confirming cell survival and
myogenic expression of implanted cells. Implanted skeletal mus-
cle cells had organized sarcomeres with elongated morphology
characteristic of fused multinucleated myotubes (original magni-
fication 400). B, Codetection of engrafted skeletal muscle cells
and native cardiomyocytes with antibody to fast skeletal-specific
isoform of myosin heavy chain (MY32, brown) and gap junction
protein connexin 43 (red dots). Absence of connexin 43 within
grafted cells or between grafted cells and microenvironment
most likely means no electrical coupling between grafted myo-
blasts or myotubes and cardiomyocytes (original magnification
200).shown).
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All sheep were killed 60  2 days after PAB with or without
cellular or placebo injection in the right ventricle. After hemody-
namic assessment with pressure-volume loops, heparin (10,000
IU) and 60 mg/kg sodium pentobarbital were injected intrave-
nously. The heart was exposed, and the pulmonary trunk and the
atria were removed from the heart, which was then weighed. The
right ventricle was cut and weighed before being fixed with 10%
formalin for evaluation.
Formalin-fixed, paraffin-embedded blocks were processed. Se-
rial 5-m sections from the harvested area were prepared for
hematoxylin-eosin staining and immunostaining. Immunohisto-
chemical examination was performed with an automated immuno-
peroxidase technique (Ventana Medical Systems, Inc, Tucson,
Ariz) with primary monoclonal antibodies directed against a fast
skeletal-specific isoform of myosin heavy chain (MY32; Sigma, St
Louis, Mo) and connexin 43 (Sigma), a component of gap
junctions.
Statistical Analysis
Indices of cardiac function (developed pressure, dP/dt , dP/
Figure 3. Right ventricular training resulted in incr
developed pressure (A), dP/dtmax (B), PRSW (C), and dmax
dtmin, PRSW slope) and weight from baseline to last day of
1122 The Journal of Thoracic and Cardiovascular Surgery ● Maprotocol and parameters evaluated at death only (heart, right ven-
tricular, and left ventricular weights, right ventricular/heart weight
ratio, and right ventricular diameter) were recorded and analyzed
with the SAS software package (8.2; SAS Institute, Inc, Cary, NC)
by either Wilcoxon signed rank test for paired and unpaired data,
nonparametric analysis of covariance, or Kruskal-Wallis test. The
data are presented as mean  SD.
Results
Cellular Implantation and Cell Survival
The injection procedure was carried out uneventfully in all
animals. Clinical status of the first 2 animals of group 2 (cell
therapy) deteriorated during 2 weeks, at which point both
animals were killed. It was found that both had pericardial
and pleural effusion and a highly edematous right ventric-
ular free wall. We decided at this stage to reduce the number
of injections from 20 to 10. All other animals with injections
in the right ventricle had an uneventful course until the day
they were killed. Arrhythmias were only noticed at the time
d signs of contractility, as assessed by increased
in (D).ease
P/dtmof needle penetration and resolved fully after injections.
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as well as on the day the animals were killed failed to show
any arrhythmogenic effect of either cellular or placebo
injections. There was no debility associated with the biopsy
in the CCM group. There were no statistically significant
differences in right ventricular weight, left ventricular
weight, and right ventricular/total heart weight ratio among
the three groups.
Aliquots of each grafted cell preparation were analyzed
to confirm cell viability and myogenic differentiation. Con-
trol culture flasks were inspected daily. Immunodetection of
the regulatory factor MyoD showed that at least 50% of the
cultured cells were skeletal muscle precursor cells (Figure
1). When the cells were left to fuse, all flasks were covered
with numerous myotubes after 1 week of culture.
Skeletal myosin heavy chain (MY32) expression was
detected at 2 months after noncultured cell implantation
in 5 of 5 animals of group 2, confirming cell survival and
skeletal muscle expression of implanted cells. Large ar-
eas of engraftment and discrete loci were noted within the
myocardial wall (Figure 2, A). Inside the myocardial
wall, the MY32 positive fibers were generally aligned
with native cardiomyocytes. None of these displayed
connexin 43 as assayed by immunohistochemical meth-
ods (Figure 2, B). Organized sarcomeres developed in
implanted skeletal muscle cells. Replacement fibrosis and
areas showing inflammatory mononuclear cells were also
present. Myocardium of control animals without implan-
tation or implanted with medium alone did not show any
Figure 4. Typical example of pressure-volume loops un
of ventricular training. Loops shifted leftward and incMY32 expression.
The Journal of ThoracicHemodynamics
Right ventricular training resulted in increased signs of
contractility, as assessed by increases in developed pressure,
dP/dtmax, and dP/dtmin obtained during baseline measure-
ment and PRSW obtained from pressure-volume loop anal-
ysis (Figure 3). The pressure-volume loops shifted leftward
and increased in height (Figure 4). This change was statis-
tically significant for all variables except dP/dtmax. There
were no observed differences, however, among the three
groups in the latter signs of cardiac function, except for
dP/dtmin, which was strongly increased in animals with PAB
and placebo (group 3 vs group 1 P  .0001, group 3 vs
group 2 P  .0001), and developed pressures, which were
also increased in this group (group 3 vs group 1 P  .0001;
Figure 5).
Discussion
Basic and clinical research on cell transplantation has
mainly focused on ischemic heart disease, because myocar-
dial infarction is the leading cause of heart failure and death
in developed countries. Ongoing work in our laboratory is
also underway regarding the benefit of grafting noncultured
cells in dilated cardiomyopathy in a large animal model. But
we thought that congenital diseases such as transposition of
the great arteries could also benefit from this novel ap-
proach. To our knowledge, this is the first report of cellular
transplantation for a model of congenital condition of the
subpulmonary ventricle. This approach could theoretically
aval occlusion before (gray) and after (black) 2 months
d in height.der c
reasebe applied to retrain a left ventricle before ASO and also to
and Cardiovascular Surgery ● Volume 129, Number 5 1123
Surgery for Congenital Heart Disease Borenstein et al
CH
Dtreat the failing right ventricle long term after ASO. The
4-month-old sheep model was used to be outside the period
of potential native hyperplasia of neonatal cardiomyocytes
and study only the functional effect of exogenous cell
Figure 5. There was no additional hemodynamic bene
(group 1) in contractility, as assessed by developed ptransplantation.
1124 The Journal of Thoracic and Cardiovascular Surgery ● MaThe report presented here draws the attention to the
interest in noncultured muscle cells for right ventricular
CCM. Our group in a previous report16 showed that non-
cultured muscle cells can be a cell source for CCM. Ad-
cell therapy and PAB (group 2) relative to PAB alone
re (A), dP/dtmax (B), dP/dtmin (C), and PRSW (D).fit to
ressuvantages to using noncultured cells as opposed to cultured
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Dsatellite cells are the lower cost, the reduced time lag
between harvest and grafting, and the diminished risk of
contamination. This technique requires a biopsy in the
morning and a grafting procedure 3 hours later.
Numerous right ventricular sections had areas covered
with skeletal myosin heavy chain (MY32)–positive fibers at
Figure 5. Continued. Fo2 months after implantation. Considering the small number
The Journal of Thoracicof cells injected (a maximum of 20  106 cells, 50%
identified as skeletal muscle precursor cells in control cul-
tures) and the engraftment observed on many sections of all
the hearts, active cellular divisions must have happened.
Therefore the fact that we did not observe a functional
benefit in the cell transplantation group is not related to a
nd see opposite page.r legecomplete failure of the engraftment.
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DReliable assessment of global right ventricular function
was achieved with the analysis of pressure-volume loops,
thanks to the conductance catheter technique, which is a
well-validated tool in animals and human subjects for the
assessment of left ventricular function. Right ventricular
function has also been explored with conductance catheter–
acquired pressure-volume loops in rabbits, dogs, pigs, and
lambs.12,18-25
Our results show that noncultured cells can massively
engraft into ovine right ventricular myocardium. Successful
engraftment, however, did not translate into a functional
benefit that we could demonstrate. Several hypotheses could
be proposed.
CCM has been proposed as an alternative strategy for
augmenting the function of diseased myocardium. However,
the myocardial environment we investigated was not diseased
but subject to chronic pressure overload. It is likely that the cell
implantation contribution could only be a moderate adjunct to
the remarkable hypertrophy induced by PAB.
Targeted regional administration implies either transmyo-
cardial or intracoronary delivery. The very small muscle frag-
ments still present in our cell preparation precluded intracoro-
nary administration. Indeed, a pilot study we carried out on a
dilated cardiomyopathy model yielded acute myocardial isch-
emia and death in all animals exposed to intracoronary non-
cultured cells (unpublished data). Epicardial injections were
therefore carried out.
Myocardial injury induced by the numerous punctures
remains a serious concern. The first 2 animals of the cell
therapy group died of right heart failure from myocardial
edema of the right ventricle. Considering the thin wall of the
right ventricle, it is likely that both the punctures and the
volume occupied by the cell preparation were detrimental.
Diminishing the number of injections resolved the problem
but also limited the extent of treated myocardium. It is
possible that this limitation in technique of administration
accounts for lack of hemodynamic benefit; perhaps more
injections would be required. Considering our experience,
only sequential injections (at varying time points) could be
performed. Minimally invasive and interventional ap-
proaches would therefore have to be used.
Perhaps another cell type should be investigated. For the
left ventricle, mesenchymal or other stem cells are interest-
ing options. If satellite cells have no demonstrable effects,
however, it is doubtful that stem cells would have a much
more visible effect.
One limitation of this study is the small sample size and
thus lack of statistical power. Had we benefited from a
larger series of animals in all groups, perhaps we would
have observed a small difference between the groups. How-
ever, it is likely that regardless of the cell type and the route
of delivery, cellular therapy is probably not useful to
strengthen a retrained left ventricle through PAB before
1126 The Journal of Thoracic and Cardiovascular Surgery ● MaASO. Whether cell transplantation can really affect the
outcome of right ventricular failure long term after ASO is
another unsettled question. A development of our research
would be studying the long-term effect (6 months to 1 year)
of cell therapy as an adjunct to PAB. Indeed, CCM might
result in a more prolonged period of preserved right ven-
tricular function. Another option would be studying the effect
of cell therapy performed only after right ventricular failure has
developed. This clinical context would be somewhat similar to
that of patients with former ASOs who could not benefit from
double-switch preparation and transformation and thus might
receive functional benefit. Although no data are available re-
garding the precise number of potential patients, this indication
would be of great interest. Still preliminary, this investigation
paves the way for further research on CCM, right ventricular
failure, and congenital heart disease.
In conclusion, our data indicate that noncultured muscle
cell transplantation in the retrained right ventricle is feasi-
ble. However, successful engraftment did not translate into
a hemodynamic benefit.
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